Gustave Roussy, the parent institution and medical partner of Gustave Roussy International Egypt, has been named the top-ranked specialized hospital in Europe and the third-best globally in Newsweek’s World’s Best Specialized Hospitals 2027 rankings. The prestigious index recognises leading healthcare institutions worldwide for their clinical excellence, specialization, and expert care.
The ranking highlights Gustave Roussy’s established global standing in clinical care, scientific research, innovation, and patient-centred treatment, which have solidified its position as a world-leading oncology institution over recent decades.
The recognition also underscores the high level of expertise behind Gustave Roussy International Egypt, the institution’s first overseas branch. The Egyptian facility brings the parent hospital’s medical expertise, clinical standards, and multidisciplinary care model directly to patients in Egypt and the wider region.
The model adopted by Gustave Roussy International Egypt combines Egyptian and French medical expertise through active cooperation, knowledge sharing, professional training, and specialized consultations. This partnership supports integrated treatment pathways and improves access to specialized care aligned with the latest global practices.
Dr Tarek Moharram, Founder and CEO of Elevate Capital, said the ranking reflects the international standing Gustave Roussy has built in oncology and demonstrates the strength of the medical model implemented at Gustave Roussy International Egypt.
“We remain committed to delivering this model in Egypt through the integration of Egyptian and French expertise, multidisciplinary care, innovation, and putting patients at the centre of every treatment decision,” Dr Moharram said.
Gustave Roussy International Egypt continues to expand its integrated oncology care model, combining Egyptian and French medical expertise to bring international standards and experience closer to patients across Egypt and the region.
